AA

Abhishek Aggrawal

Active Director Whole-Time Director DIN 10264964
DIN 10264964 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Aug 2023
Shareholding value •••• Premium profile

About Abhishek Aggrawal

Data last updated:

Abhishek Aggrawal is a Whole-Time Director at Ck Birla Healthcare Private Limited (since 2023), Director at Babyscience Ivf Clinics Private Limited (since 2024) and Director at Asian Reproductive Centre Private Limited (since 2024), and holds 4 more current directorships. The companies operate in Healthcare. The 7 current companies with reported revenue have a combined latest revenue of ₹446 Cr; the largest is Ck Birla Healthcare Private Limited at ₹386 Cr (FY 2025).

DIN 10264964
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 02 Aug 2023
Oldest Company Age 22 yrs
Largest company Ck Birla Healthcare Private Limited · ₹386 Cr (FY 2025)
Combined revenue ₹446 Cr across 7 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ck Birla Healthcare Private Limited U74140DL2014PTC272562
Whole-Time Director02 Aug 20232014₹386 Cr (FY 2025)Active
Director23 Aug 20242020₹24.10 Cr (FY 2025)Active
Director01 Jul 20242014₹17.58 Cr (FY 2025)Active
Director01 Jul 20242015₹8.87 Cr (FY 2025)Active
Director01 Jul 20242012₹4.62 Cr (FY 2025)Active
Director23 Aug 20242004₹3.29 Cr (FY 2025)Active
Salem Ivf Centre Private Limited U74999DL2014PTC453100
Director01 Jul 20242014₹1.75 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Repro Health Care Mangalore Private Limited
Thrissur Repro Health Care Private Limited
Asian Reproductive Centre Private Limited
Salem Ivf Centre Private Limited
Premium access

Shareholding and investment profile for Abhishek Aggrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Aggrawal

Abhishek Aggrawal currently holds 7 directorships: Ck Birla Healthcare Private Limited (Whole-Time Director, since 02 Aug 2023, revenue ₹386 Cr (FY 2025)); Babyscience Ivf Clinics Private Limited (Director, since 23 Aug 2024, revenue ₹24.10 Cr (FY 2025)); Asian Reproductive Centre Private Limited (Director, since 01 Jul 2024, revenue ₹17.58 Cr (FY 2025)); Thrissur Repro Health Care Private Limited (Director, since 01 Jul 2024, revenue ₹8.87 Cr (FY 2025)); Repro Health Care Mangalore Private Limited (Director, since 01 Jul 2024, revenue ₹4.62 Cr (FY 2025)); and 2 more.

Abhishek Aggrawal was first appointed on 02 Aug 2023 as Whole-Time Director at Ck Birla Healthcare Private Limited. The most recent appointment on record is 23 Aug 2024 at Centre Of Human Reproduction And Biosciences Private Limited.

The 7 current companies of Abhishek Aggrawal that report revenue have a combined latest revenue of ₹446 Cr: Ck Birla Healthcare Private Limited ₹386 Cr (FY 2025); Babyscience Ivf Clinics Private Limited ₹24.10 Cr (FY 2025); Asian Reproductive Centre Private Limited ₹17.58 Cr (FY 2025); Thrissur Repro Health Care Private Limited ₹8.87 Cr (FY 2025); Repro Health Care Mangalore Private Limited ₹4.62 Cr (FY 2025); and 2 more.

The current boards of Abhishek Aggrawal's companies include Akshat Seth (Ck Birla Healthcare Private Limited), Avanti Birla (Ck Birla Healthcare Private Limited), Monika Srivastava (Ck Birla Healthcare Private Limited), Ranjana (Ck Birla Healthcare Private Limited), Shyam Sunder Sharma (Ck Birla Healthcare Private Limited), Srinivasa Varadhan Tirumalai Echambadi (Ck Birla Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available